[{"NetIncomeLoss_1_Q1_USD":-95764000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":51420000.0,"TreasuryStockCommonShares_0_Q1_shares":3033.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-236000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":1269000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-658816000.0,"Depreciation_1_Q1_USD":2582000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":708000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":458000.0,"AssetsCurrent_0_Q1_USD":2051866000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":841786000.0,"ProceedsFromCollaborators_1_Q1_USD":1000000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":8270344.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":4687000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-651000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":182970000.0,"CommonStockSharesIssued_0_Q1_shares":58409854.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_1_Q1_USD":24766000.0,"Assets_0_Q1_USD":2080698000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-651000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":39847000.0,"IncrementalCommonSharesAttributableToConversionOfPreferredStock_1_Q1_shares":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":58374219.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"ResearchAndDevelopmentExpense_1_Q1_USD":58056000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1_Q1_shares":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":58374219.0,"AssetsFairValueDisclosure_0_Q1_USD":2004017000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":35000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q1_USD":-1325000.0,"CommonStockValue_0_Q1_USD":6000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":5623000.0,"RestrictedCash_0_Q1_USD":700000.0,"MarketableSecuritiesCurrent_0_Q1_USD":1104767000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-96415000.0,"OtherAssetsNoncurrent_0_Q1_USD":3392000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":899250000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":15411000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":3137164000.0,"Liabilities_0_Q1_USD":77422000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q1_shares":1286175.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":5623000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-651000.0,"TreasuryStockCommonValue_0_Q1_USD":400000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-406000.0,"ShareBasedCompensation_1_Q1_USD":21976000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":19998000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"AssetImpairmentCharges_1_Q1_USD":0.0,"CommonStockSharesOutstanding_0_Q1_shares":58406821.0,"InvestmentsFairValueDisclosure_0_Q1_USD":1104767000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":4652000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":222000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":21734000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-109086000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":58374219.0,"LiabilitiesCurrent_0_Q1_USD":62011000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-762279000.0,"AccountsPayableCurrent_0_Q1_USD":3285000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":899250000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":687000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease_1_Q1_USD":-1800000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":900519000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":936000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease_1_Q1_USD":-1800000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":4173000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":23083000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1133258000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":10024525.0,"AccountsReceivableRelatedPartiesCurrent_0_Q1_USD":24766000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":54.93,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":262000.0,"CommonStockSharesAuthorized_0_Q1_shares":120000000.0,"OperatingIncomeLoss_1_Q1_USD":-96507000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q1_shares":4743725.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":1104767000.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":2080698000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":3640000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":21976000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":8825000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":7306000.0,"DeferredRevenueAdditions_1_Q1_USD":606100000.0,"OperatingExpenses_1_Q1_USD":98090000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-4140000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.64,"ProfitLoss_1_Q1_USD":-95764000.0,"StockholdersEquity_0_Q1_USD":2003276000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":1105003000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":51000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":7817000.0,"Ticker":"SAGE","CIK":"1597553","name":"SAGE THERAPEUTICS, INC.","OfficialName":"Sage Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2034401653.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210504"}]